These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9223816)

  • 41. Acute presentation of tophaceous myelopathy.
    Levin E; Hurth K; Joshi R; Brasington R
    J Rheumatol; 2011 Jul; 38(7):1525-6. PubMed ID: 21724731
    [No Abstract]   [Full Text] [Related]  

  • 42. [Tophaceous gout].
    Moriwaki Y
    Nihon Rinsho; 2008 Apr; 66(4):711-6. PubMed ID: 18409520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultrasonographic measurement of tophi as an outcome measure for chronic gout.
    Perez-Ruiz F; Martin I; Canteli B
    J Rheumatol; 2007 Sep; 34(9):1888-93. PubMed ID: 17659752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Destructive tophaceous gout: imaging characteristics.
    Sky K; Austad GT; Higgs J
    J Clin Rheumatol; 2011 Sep; 17(6):346. PubMed ID: 21885929
    [No Abstract]   [Full Text] [Related]  

  • 45. Large tophi and nodal arthritis.
    Galen BT; Federman DG
    J Clin Rheumatol; 2014 Sep; 20(6):336. PubMed ID: 25160021
    [No Abstract]   [Full Text] [Related]  

  • 46. Crystal-associated arthritis in the elderly.
    Wise CM
    Clin Geriatr Med; 2005 Aug; 21(3):491-511, v-vi. PubMed ID: 15911203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dual-energy computer tomography can be used for gout diagnostics].
    Jørgensen SH; Knudsen ET; Rasmussen C
    Ugeskr Laeger; 2015 Aug; 177(33):V10140544. PubMed ID: 26320353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 49. Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.
    Stevenson M; Pandor A
    Health Technol Assess; 2009 Oct; 13 Suppl 3():37-42. PubMed ID: 19846027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Achieving serum urate goal: a comparative effectiveness study between allopurinol and febuxostat.
    Hatoum H; Khanna D; Lin SJ; Akhras KS; Shiozawa A; Khanna P
    Postgrad Med; 2014 Mar; 126(2):65-75. PubMed ID: 24685969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
    Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
    N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tophaceous gout of the first costochondral junction in a heart transplant patient.
    Chang PC; Seeger LL; Motamedi K; Chan JB
    Skeletal Radiol; 2006 Sep; 35(9):684-6. PubMed ID: 16003547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions.
    Chohan S
    J Rheumatol; 2011 Sep; 38(9):1957-9. PubMed ID: 21724706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Massive gouty pseudotumor.
    Medina YF; Matteson EL
    J Clin Rheumatol; 2012 Dec; 18(8):451. PubMed ID: 23211589
    [No Abstract]   [Full Text] [Related]  

  • 55. Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout.
    Aati O; Taylor WJ; Horne A; Dalbeth N
    J Clin Rheumatol; 2014 Aug; 20(5):251-5. PubMed ID: 25036566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rogue one: a story of tophaceous gout in the spine.
    Dwarki K; Dothard A; Abadie B; Miles MC
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29666075
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia.
    Huang X; Du H; Gu J; Zhao D; Jiang L; Li X; Zuo X; Liu Y; Li Z; Li X; Zhu P; Li J; Zhang Z; Huang A; Zhang Y; Bao C
    Int J Rheum Dis; 2014 Jul; 17(6):679-86. PubMed ID: 24467549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pegloticase and the patient with treatment-failure gout.
    Dave AJ; Kelly VM; Krishnan E
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial.
    Taylor TH; Mecchella JN; Larson RJ; Kerin KD; Mackenzie TA
    Am J Med; 2012 Nov; 125(11):1126-1134.e7. PubMed ID: 23098865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective.
    Gandhi PK; Gentry WM; Ma Q; Bottorff MB
    J Manag Care Spec Pharm; 2015 Feb; 21(2):165-75. PubMed ID: 25615006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.